Enterprise Value
967.8M
Cash
349.3M
Avg Qtr Burn
-72.9M
Short % of Float
30.60%
Insider Ownership
11.22%
Institutional Own.
91.09%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SC291 Details B-cell malignancies | Phase 1 Interim update |